Ingrédients pharmaceutiques

트리메부틴 말레산염 은 항무스카린성 및 약한 뮤 오피오이드 작용제 효과가 있는 약물입니다. 과민성 대장 증후군 및 기타 위장 장애의 치료에 사용됩니다. 

REFARMED CHEMICALS proudly introduces Levetiracetam, a versatile antiepileptic medication essential for the management of seizure disorders. This innovative product is formulated to provide relief for individuals suffering from partial-onset seizures, myoclonic seizures, and primary generalized tonic-clonic seizures. Recommended for both adults and children, Levetiracetam is an indispensable pharmaceutical geared towards enhancing the quality of life for patients aged 6 years and older. Crafted with utmost precision, Levetiracetam is available in tablets, oral solution, and intravenous solution, delivering flexibility and convenience in administration. The active ingredient binds to synaptic vesicle protein 2A within the brain, mitigating the release of neurotransmitters that incite seizures, thereby providing effective seizure control with a reliable and targeted mechanism of action. REFARMED CHEMICALS, a global pharmaceutical leader situated in Mexico City, adheres to the highest standards of quality and efficacy. With rigorous certifications, including GMP and WC, our Levetiracetam meets and exceeds industry specifications. The product presents as a white or almost white powder, demonstrating high solubility in water among other solvents, ensuring ease of formulation into various dosages. While side effects such as somnolence, asthenia, and dizziness can occur, Levetiracetam remains a top choice for patients and healthcare providers alike. The prudent approach to treatment involves discussing potential interactions with other medications and considering precautions, particularly for those with kidney conditions. Our commitment to delivering high-caliber, affordable medical solutions is unrivaled. Levetiracetam from REFARMED CHEMICALS, both in generic and brand formulations, signifies our dedication to empowering healthcare professionals and patients with reliable, accessible, and high-quality therapeutic options. Trust in REFARMED CHEMICALS – your partner in progressive healthcare solutions.

Products still subject to third-party patent protection might be available solely for R&D purposes.

Ketotifen Hydrogen Fumarate is a specialized pharmaceutical compound with profound implications in the management of allergic conditions. As a white to off-white crystalline powder, it embodies the archetypal pharmaceutical intermediate that serves a critical role in the synthesis of medications aimed at mitigating allergic symptoms. This compound, with the molecular formula C19H19NOS·C4H4O4 and a molecular weight of 425.50 g/mol, is an epitome of pharmacological innovation, designed to alleviate discomfort associated with allergic rhinitis and conjunctivitis, while also playing a preventive role in asthma management. Fabricated with meticulous precision, Ketotifen Hydrogen Fumarate is both soluble in water and ethanol, ensuring versatility in its application for medical formulations. With a melting point between 160-163°C, where it starts decomposing, this substance remains stable under a wide range of conditions, ensuring a dependable shelf-life for pharmaceutical products. When handling this product, adherence to stringent safety guidelines, including the use of personal protective equipment, is imperative to minimize potential contact risks. It demands storage in cool, dry environments, shielded from light and moisture, to preserve its integrity. Respected for its non-sedating nature, Ketotifen distinctively works by inhibiting the discharge of histamine and other mediators from mast cells, thus curtailing the cascade of allergic reactions without inducing significant drowsiness. The side effects are minimal, with mild drowsiness, dry mouth, and nausea being among the most common, while more severe reactions such as confusion or hallucinations are decidedly rare. An advocate for quality and safety, Refarmed Chemicals, a leading pharmaceutical ingredient manufacturer, assures regulatory compliance, with Ketotifen Hydrogen Fumarate approved by the FDA for prescribed use. As such, corporate customers seeking a reliable cornerstone for their allergy-treating formulations will find this product to be a formidable addition to their pharmaceutical repertoire.

Products still subject to third-party patent protection might be available solely for R&D purposes.